Considering that microtubule-associated tumor suppressors (such as breast cancer 1, BRCA1) can have major impact on cancer aggressiveness and clinical outcome [75], microtubule rearrangement through s-μg can indeed be a tool to influence the latter. The gene discussed is BRCA1; the disease is cancer.